Johnson & Johnson has agreed to pay $120 million to attorneys general in 46 states and Washington, D.C., to resolve marketing claims brought over its hip implants.

The settlement, announced on Tuesday, is the largest agreement that New Jersey-based Johnson & Johnson has made with attorneys general over its ASR XL and Pinnacle Ultamet hip implants, made by its Medical Device Business Inc. division, formerly known as DePuy Orthopaedics Inc. In 2014, Johnson & Johnson paid $4 million to settle a case brought by the Oregon Department of Justice over its ASR hip implants.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]